Low-cost Tools for Diagnosing and Monitoring HIV Infection in Low-resource Settings

Overview

Journal Bull World Health Organ

Specialty Public Health

Date 2013 Jan 4

PMID 23284197

Citations 70

Authors

Grace Wu

Muhammad H Zaman

Affiliations

Soon will be listed here.

Abstract

Low-cost technologies to diagnose and monitor human immunodeficiency virus (HIV) infection in developing countries are a major subject of current research and health care in the developing world. With the great need to increase access to affordable HIV monitoring services in rural areas of developing countries, much work has been focus on the development of point-of-care technologies that are affordable, robust, easy to use, portable and of sufficient quantitative accuracy to enable clinical decision-making. For diagnosis of HIV infection, some low-cost tests, such as lateral flow tests and enzyme-linked immunosorbent assays, are already in place and well established. However, portable quantitative tests for rapid HIV monitoring at the point of care have only recently been introduced to the market. In this review, we discuss low-cost tests for HIV diagnosis and monitoring in low-resource settings, including promising technologies for use at the point of care, that are available or close to market.

Citing Articles

Microfluidic point-of-care testing device for multiplexed detection of liver function blood markers.

Li Y, Cheng H Biomed Opt Express. 2024; 15(10):5803-5817.

PMID: 39421784 PMC: 11482181. DOI: 10.1364/BOE.533855.

The Evolution of Nucleic Acid-Based Diagnosis Methods from the (pre-)CRISPR to CRISPR era and the Associated Machine/Deep Learning Approaches in Relevant RNA Design.

Chakraborty S, Ray Dutta J, Ganesan R, Minary P Methods Mol Biol. 2024; 2847:241-300.

PMID: 39312149 DOI: 10.1007/978-1-0716-4079-1_17.

SERS biosensors for liquid biopsy towards cancer diagnosis by detection of various circulating biomarkers: current progress and perspectives.

Lyu N, Hassanzadeh-Barforoushi A, Rey Gomez L, Zhang W, Wang Y Nano Converg. 2024; 11(1):22.

PMID: 38811455 PMC: 11136937. DOI: 10.1186/s40580-024-00428-3.

Self-Powered Microfluidics for Point-of-Care Solutions: From Sampling to Detection of Proteins and Nucleic Acids.

Vloemans D, Van Hileghem L, Ordutowski H, Dal Dosso F, Spasic D, Lammertyn J Methods Mol Biol. 2024; 2804:3-50.

PMID: 38753138 DOI: 10.1007/978-1-0716-3850-7_1.

The Role and Value of Professional Rapid Testing of Acute Respiratory Infections (ARIs) in Europe: A Special Focus on the Czech Republic, Poland, and Romania.

Drevinek P, Flisiak R, Nemes R, Nogales Crespo K, Tomasiewicz K Diagnostics (Basel). 2024; 14(6).

PMID: 38535051 PMC: 10969707. DOI: 10.3390/diagnostics14060631.

References

Tanriverdi S, Chen L, Chen S . A rapid and automated sample-to-result HIV load test for near-patient application. J Infect Dis. 2010; 201 Suppl 1:S52-8. DOI: 10.1086/650387. View

Branson B . The future of HIV testing. J Acquir Immune Defic Syndr. 2011; 55 Suppl 2:S102-5. DOI: 10.1097/QAI.0b013e3181fbca44. View

Mtapuri-Zinyowera S, Chideme M, Mangwanya D, Mugurungi O, Gudukeya S, Hatzold K . Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J Acquir Immune Defic Syndr. 2010; 55(1):1-7. DOI: 10.1097/QAI.0b013e3181e93071. View

Stevens W, Scott L, Crowe S . Quantifying HIV for monitoring antiretroviral therapy in resource-poor settings. J Infect Dis. 2010; 201 Suppl 1:S16-26. DOI: 10.1086/650392. View

Steegen K, Luchters S, De Cabooter N, Reynaerts J, Mandaliya K, Plum J . Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings. J Virol Methods. 2007; 146(1-2):178-87. DOI: 10.1016/j.jviromet.2007.06.019. View

Desai D, Wu G, Zaman M . Tackling HIV through robust diagnostics in the developing world: current status and future opportunities. Lab Chip. 2010; 11(2):194-211. PMC: 5181793. DOI: 10.1039/c0lc00340a. View

Workman S, Wells S, Pau C, Owen S, Dong X, LaBorde R . Rapid detection of HIV-1 p24 antigen using magnetic immuno-chromatography (MICT). J Virol Methods. 2009; 160(1-2):14-21. DOI: 10.1016/j.jviromet.2009.04.003. View

Labbett W, Garcia-Diaz A, Fox Z, Clewley G, Fernandez T, Johnson M . Comparative evaluation of the ExaVir Load version 3 reverse transcriptase assay for measurement of human immunodeficiency virus type 1 plasma load. J Clin Microbiol. 2009; 47(10):3266-70. PMC: 2756939. DOI: 10.1128/JCM.00715-09. View

Nabatiyan A, Baumann M, Parpia Z, Kelso D . A lateral flow-based ultra-sensitive p24 HIV assay utilizing fluorescent microparticles. J Acquir Immune Defic Syndr. 2009; 53(1):55-61. DOI: 10.1097/QAI.0b013e3181c4b9d5. View

10.

Curioso W, Kurth A, Cabello R, Segura P, Berry D . Usability evaluation of Personal Digital Assistants (PDAs) to support HIV treatment adherence and safer sex behavior in Peru. AMIA Annu Symp Proc. 2008; :918. View

11.

Fiscus S, Wiener J, Abrams E, Bulterys M, Cachafeiro A, Respess R . Ultrasensitive p24 antigen assay for diagnosis of perinatal human immunodeficiency virus type 1 infection. J Clin Microbiol. 2007; 45(7):2274-7. PMC: 1933021. DOI: 10.1128/JCM.00813-07. View

12.

Parisi M, Soldini L, Di Perri G, Tiberi S, Lazzarin A, Lillo F . Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programs. New Microbiol. 2010; 32(4):391-6. View

13.

George E, Beauharnais C, Brignoli E, Noel F, Bois G, Rouzier P . Potential of a simplified p24 assay for early diagnosis of infant human immunodeficiency virus type 1 infection in Haiti. J Clin Microbiol. 2007; 45(10):3416-8. PMC: 2045325. DOI: 10.1128/JCM.01314-07. View

14.

Sitoe N, Luecke E, Tembe N, Matavele R, Cumbane V, Macassa E . Absolute and percent CD4+ T-cell enumeration by flow cytometry using capillary blood. J Immunol Methods. 2011; 372(1-2):1-6. DOI: 10.1016/j.jim.2011.07.008. View

15.

Cachafeiro A, Sherman G, Sohn A, Beck-Sague C, Fiscus S . Diagnosis of human immunodeficiency virus type 1 infection in infants by use of dried blood spots and an ultrasensitive p24 antigen assay. J Clin Microbiol. 2008; 47(2):459-62. PMC: 2643698. DOI: 10.1128/JCM.01181-08. View

16.

Glencross D, Coetzee L, Faal M, Masango M, Stevens W, Venter W . Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa. J Int AIDS Soc. 2012; 15(1):3. PMC: 3310849. DOI: 10.1186/1758-2652-15-3. View

17.

Chin C, Laksanasopin T, Cheung Y, Steinmiller D, Linder V, Parsa H . Microfluidics-based diagnostics of infectious diseases in the developing world. Nat Med. 2011; 17(8):1015-9. DOI: 10.1038/nm.2408. View

18.

Tseng D, Mudanyali O, Oztoprak C, Isikman S, Sencan I, Yaglidere O . Lensfree microscopy on a cellphone. Lab Chip. 2010; 10(14):1787-92. PMC: 2941438. DOI: 10.1039/c003477k. View

19.

Mabey D, Peeling R, Ustianowski A, Perkins M . Diagnostics for the developing world. Nat Rev Microbiol. 2004; 2(3):231-40. DOI: 10.1038/nrmicro841. View

20.

Daaboul G, Yurt A, Zhang X, Hwang G, Goldberg B, Unlu M . High-throughput detection and sizing of individual low-index nanoparticles and viruses for pathogen identification. Nano Lett. 2010; 10(11):4727-31. DOI: 10.1021/nl103210p. View